Datamining in Non-Target Chemical Screening Data
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
US 2014/0116112 A1 HUMPHREY Et Al
US 201401 16112A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2014/0116112 A1 HUMPHREY et al. (43) Pub. Date: May 1, 2014 (54) METHODS FOR DETERMINING THE Publication Classification PRESENCE OR ABSENCE OF CONTAMINANTS IN A SAMPLE (51) Int. Cl. GOIN30/72 (2006.01) (71) Applicant: K & D LABORATORIES, INC., Lake (52) U.S. Cl. Oswego, OR (US) CPC .................................. G0IN30/7206 (2013.01) USPC ......................................................... T3/23.37 (72) Inventors: David Kent HUMPHREY, Reno, NV (US); Nicholas Joseph GEISE, Portland, OR (US) (57) ABSTRACT (73) Assignee: K & D LABORATORIES, INC., Lake Oswego, OR (US) Methods are provided for rapidly determining the presence or absence of large numbers of contaminants in a test sample, (21) Appl. No.: 13/830,388 Such as a raw material intended for use in the preparation of a nutraceutical. The disclosed methods employ gas chromatog (22) Filed: Mar 14, 2013 raphy-mass spectrometry techniques together with the spe cific use of software in combination with a database to ana Related U.S. Application Data lyze data collected after ionization of the sample and (60) Provisional application No. 61/718,607, filed on Oct. determine the presence or absence of the contaminants in the 25, 2012. sample. US 2014/01161 12 A1 May 1, 2014 METHODS FOR DETERMINING THE 0007. In one embodiment, methods for detecting the pres PRESENCE OR ABSENCE OF ence or absence of a plurality of contaminants in a sample are CONTAMINANTS IN A SAMPLE provided, such methods comprising: (a) extracting the sample with a water-miscible solvent in the presence of a high con REFERENCE TO RELATED APPLICATIONS centration of salts to provide a sample extract; (b) shaking and centrifuging the sample extract to provide a Supernatant; (c) 0001. -
Urinary Paraben Concentrations and Ovarian Aging Among Women from a Fertility Center
Urinary Paraben Concentrations and Ovarian Aging among Women from a Fertility Center The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Smith, Kristen W., Irene Souter, Irene Dimitriadis, Shelley Ehrlich, Paige L. Williams, Antonia M. Calafat, and Russ Hauser. 2013. “Urinary Paraben Concentrations and Ovarian Aging among Women from a Fertility Center.” Environmental Health Perspectives 121 (11-12): 1299-1305. doi:10.1289/ehp.1205350. http://dx.doi.org/10.1289/ehp.1205350. Published Version doi:10.1289/ehp.1205350 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11879222 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA All EHP content is accessible to individuals with disabilities. A fully accessible (Section 508–compliant) HTML version of this article is available at http://dx.doi.org/10.1289/ehp.1205350. Research Urinary Paraben Concentrations and Ovarian Aging among Women from a Fertility Center Kristen W. Smith,1 Irene Souter,2 Irene Dimitriadis,1,2 Shelley Ehrlich,1 Paige L. Williams,3 Antonia M. Calafat,4 and Russ Hauser1,2 1Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts, USA; 2Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Harvard Medical School/Massachusetts General Hospital Fertility Center, Boston, Massachusetts, USA; 3Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA; 4National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA In 2008, the Cosmetic Ingredient Review BACKGROUND: Parabens are preservatives commonly used in personal care products, pharmaceuticals, Panel concluded that parabens used in cos- and foods. -
The National Drugs List
^ ^ ^ ^ ^[ ^ The National Drugs List Of Syrian Arab Republic Sexth Edition 2006 ! " # "$ % &'() " # * +$, -. / & 0 /+12 3 4" 5 "$ . "$ 67"5,) 0 " /! !2 4? @ % 88 9 3: " # "$ ;+<=2 – G# H H2 I) – 6( – 65 : A B C "5 : , D )* . J!* HK"3 H"$ T ) 4 B K<) +$ LMA N O 3 4P<B &Q / RS ) H< C4VH /430 / 1988 V W* < C A GQ ") 4V / 1000 / C4VH /820 / 2001 V XX K<# C ,V /500 / 1992 V "!X V /946 / 2004 V Z < C V /914 / 2003 V ) < ] +$, [2 / ,) @# @ S%Q2 J"= [ &<\ @ +$ LMA 1 O \ . S X '( ^ & M_ `AB @ &' 3 4" + @ V= 4 )\ " : N " # "$ 6 ) G" 3Q + a C G /<"B d3: C K7 e , fM 4 Q b"$ " < $\ c"7: 5) G . HHH3Q J # Hg ' V"h 6< G* H5 !" # $%" & $' ,* ( )* + 2 ا اوا ادو +% 5 j 2 i1 6 B J' 6<X " 6"[ i2 "$ "< * i3 10 6 i4 11 6! ^ i5 13 6<X "!# * i6 15 7 G!, 6 - k 24"$d dl ?K V *4V h 63[46 ' i8 19 Adl 20 "( 2 i9 20 G Q) 6 i10 20 a 6 m[, 6 i11 21 ?K V $n i12 21 "% * i13 23 b+ 6 i14 23 oe C * i15 24 !, 2 6\ i16 25 C V pq * i17 26 ( S 6) 1, ++ &"r i19 3 +% 27 G 6 ""% i19 28 ^ Ks 2 i20 31 % Ks 2 i21 32 s * i22 35 " " * i23 37 "$ * i24 38 6" i25 39 V t h Gu* v!* 2 i26 39 ( 2 i27 40 B w< Ks 2 i28 40 d C &"r i29 42 "' 6 i30 42 " * i31 42 ":< * i32 5 ./ 0" -33 4 : ANAESTHETICS $ 1 2 -1 :GENERAL ANAESTHETICS AND OXYGEN 4 $1 2 2- ATRACURIUM BESYLATE DROPERIDOL ETHER FENTANYL HALOTHANE ISOFLURANE KETAMINE HCL NITROUS OXIDE OXYGEN PROPOFOL REMIFENTANIL SEVOFLURANE SUFENTANIL THIOPENTAL :LOCAL ANAESTHETICS !67$1 2 -5 AMYLEINE HCL=AMYLOCAINE ARTICAINE BENZOCAINE BUPIVACAINE CINCHOCAINE LIDOCAINE MEPIVACAINE OXETHAZAINE PRAMOXINE PRILOCAINE PREOPERATIVE MEDICATION & SEDATION FOR 9*: ;< " 2 -8 : : SHORT -TERM PROCEDURES ATROPINE DIAZEPAM INJ. -
Factors Influencing Pesticide Resistance in Psylla Pyricola Foerster and Susceptibility Inits Mirid
AN ABSTRACT OF THE THESIS OF: Hugo E. van de Baan for the degree ofDoctor of Philosopbv in Entomology presented on September 29, 181. Title: Factors Influencing Pesticide Resistance in Psylla pyricola Foerster and Susceptibility inits Mirid Predator, Deraeocoris brevis Knight. Redacted for Privacy Abstract approved: Factors influencing pesticide susceptibility and resistance were studied in Psylla pyricola Foerster, and its mirid predator, Deraeocoris brevis Knight in the Rogue River Valley, Oregon. Factors studied were at the biochemical, life history, and population ecology levels. Studies on detoxification enzymes showed that glutathione S-transferase and cytochrome P-450 monooxygenase activities were ca. 1.6-fold higherin susceptible R. brevis than in susceptible pear psylla, however, esterase activity was ca. 5-fold lower. Esterase activity was ca. 18-fold higher in resistant pear psylla than in susceptible D. brevis, however, glutathione S-transferase and cytochrome P-450 monooxygenase activities were similar. Esterases seem to be a major factor conferring insecticideresistance in P. Pvricola. Although the detoxification capacities of P. rivricola and D. brevis were quite similar, pear psylla has developed resistance to many insecticides in the Rogue River Valley, whereas D. brevis has remained susceptible. Biochemical factors may be important in determining the potential of resistance development, however, they are less important in determining the rate at which resistance develops. Computer simulation studies showed that life history and ecological factors are probably of greater importancein determining the rate at which resistance develops in P. pvricola and D. brevis. High fecundity and low immigration of susceptible individuals into selected populations appear to be major factors contributing to rapid resistance development in pear psylla compared with D. -
Campro Catalog Stable Isotope
Introduction & Welcome Dear Valued Customer, We are pleased to present to you our Stable Isotopes Catalog which contains more than three thousand (3000) high quality labeled compounds. You will find new additions that are beneficial for your research. Campro Scientific is proud to work together with Isotec, Inc. for the distribution and marketing of their stable isotopes. We have been working with Isotec for more than twenty years and know that their products meet the highest standard. Campro Scientific was founded in 1981 and we provide services to some of the most prestigious universities, research institutes and laboratories throughout Europe. We are a research-oriented company specialized in supporting the requirements of the scientific community. We are the exclusive distributor of some of the world’s leading producers of research chemicals, radioisotopes, stable isotopes and environmental standards. We understand the requirements of our customers, and work every day to fulfill them. In working with us you are guaranteed to receive: - Excellent customer service - High quality products - Dependable service - Efficient distribution The highly educated staff at Campro’s headquarters and sales office is ready to assist you with your questions and product requirements. Feel free to call us at any time. Sincerely, Dr. Ahmad Rajabi General Manager 180/280 = unlabeled 185/285 = 15N labeled 181/281 = double labeled (13C+15N, 13C+D, 15N+18O etc.) 186/286 = 12C labeled 182/282 = d labeled 187/287 = 17O labeled 183/283 = 13C labeleld 188/288 = 18O labeled 184/284 = 16O labeled, 14N labeled 189/289 = Noble Gases Table of Contents Ordering Information.................................................................................................. page 4 - 5 Packaging Information .............................................................................................. -
(CD-P-PH/PHO) Report Classification/Justifica
COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) Report classification/justification of medicines belonging to the ATC group D07A (Corticosteroids, Plain) Table of Contents Page INTRODUCTION 4 DISCLAIMER 6 GLOSSARY OF TERMS USED IN THIS DOCUMENT 7 ACTIVE SUBSTANCES Methylprednisolone (ATC: D07AA01) 8 Hydrocortisone (ATC: D07AA02) 9 Prednisolone (ATC: D07AA03) 11 Clobetasone (ATC: D07AB01) 13 Hydrocortisone butyrate (ATC: D07AB02) 16 Flumetasone (ATC: D07AB03) 18 Fluocortin (ATC: D07AB04) 21 Fluperolone (ATC: D07AB05) 22 Fluorometholone (ATC: D07AB06) 23 Fluprednidene (ATC: D07AB07) 24 Desonide (ATC: D07AB08) 25 Triamcinolone (ATC: D07AB09) 27 Alclometasone (ATC: D07AB10) 29 Hydrocortisone buteprate (ATC: D07AB11) 31 Dexamethasone (ATC: D07AB19) 32 Clocortolone (ATC: D07AB21) 34 Combinations of Corticosteroids (ATC: D07AB30) 35 Betamethasone (ATC: D07AC01) 36 Fluclorolone (ATC: D07AC02) 39 Desoximetasone (ATC: D07AC03) 40 Fluocinolone Acetonide (ATC: D07AC04) 43 Fluocortolone (ATC: D07AC05) 46 2 Diflucortolone (ATC: D07AC06) 47 Fludroxycortide (ATC: D07AC07) 50 Fluocinonide (ATC: D07AC08) 51 Budesonide (ATC: D07AC09) 54 Diflorasone (ATC: D07AC10) 55 Amcinonide (ATC: D07AC11) 56 Halometasone (ATC: D07AC12) 57 Mometasone (ATC: D07AC13) 58 Methylprednisolone Aceponate (ATC: D07AC14) 62 Beclometasone (ATC: D07AC15) 65 Hydrocortisone Aceponate (ATC: D07AC16) 68 Fluticasone (ATC: D07AC17) 69 Prednicarbate (ATC: D07AC18) 73 Difluprednate (ATC: D07AC19) 76 Ulobetasol (ATC: D07AC21) 77 Clobetasol (ATC: D07AD01) 78 Halcinonide (ATC: D07AD02) 81 LIST OF AUTHORS 82 3 INTRODUCTION The availability of medicines with or without a medical prescription has implications on patient safety, accessibility of medicines to patients and responsible management of healthcare expenditure. The decision on prescription status and related supply conditions is a core competency of national health authorities. -
European Journal of Chemistry 5 (4) (2014) 681‐694
European Journal of Chemistry 5 (4) (2014) 681‐694 European Journal of Chemistry Journal homepage: www.eurjchem.com Synthesis, reactions and applications of pyranotriazolopyrimidines Ashraf Hassan Fekry Abd El‐Wahab a,b,*, Ibrahim Ali Radini a and Hany Mostafa Mohamed a,b a Chemistry Department, Faculty of Science, Jazan University, 2097, Jazan, Saudi Arabia b Chemistry Department, Faculty of Science, Al‐Azhar University, 11884, Nasr City, Cairo, Egypt *Corresponding author at: Chemistry Department, Faculty of Science, Jazan University, 2097, Jazan, Saudi Arabia. Tel.: +966.054.0963753. Fax: +966.017.3230028. E‐mail address: [email protected] (A.H.F.A. El‐Wahab). REVIEW INFORMATION ABSTRACT This review deals with synthesis, reactions and their applications of pyranotriazolo‐ pyrimidines. The main purpose of this review is present a survey of literatures on the reactivity of amino imino derivatives and carboxylic acid derivatives. Some of these reactions have been applied successfully to the synthesis of biological important compounds. DOI: 10.5155/eurjchem.5.4.681‐694.1087 Received: 30 April 2014 Received in revised form: 27 May 2014 Accepted: 27 May 2014 Online: 31 December 2014 KEYWORDS Naphthols Pyrimidine Biological activity Pyranopyrimidines α‐Cyanocinnamonitriles Carboxylic acid derivatives 1. Introduction chemical and biological view points, due to their diverse pharmacological activities, such as antitumor potency [19,20], Pyran derivatives have attracted a great deal of interest inhibition of KDR kinase [21], antifungal effect [22] and owing to their antimicrobial activity [1‐7], inhibition of influ‐ macrophage activation [23]. enza, virus sialidase [8], mutagenic activity [9], activity as antiviral [10], anti‐proliferaction agents [11], sex pheromones [12], antitumor [13] and anti‐inflammatory agents [14]. -
(12) United States Patent (10) Patent No.: US 9,394,315 B2 Aicher Et Al
USOO93943 15B2 (12) United States Patent (10) Patent No.: US 9,394,315 B2 Aicher et al. (45) Date of Patent: Jul.19, 2016 (54) TETRAHYDROI18NAPHTHYRIDINE 6,605,634 B2 8, 2003 Zablocki et al. SULFONAMIDE AND RELATED 6,638,960 B2 10/2003 Assmann et al. 6,683,091 B2 1/2004 Asberomet al. COMPOUNDS FOR USEAS AGONSTS OF 6,828,344 B1 12/2004 Seehra et al. RORY AND THE TREATMENT OF DISEASE 7,084, 176 B2 8, 2006 Morie et al. 7,138.401 B2 11/2006 Kasibhatla et al. (71) Applicant: Lycera Corporation, Ann Arbor, MI 7,329,675 B2 2/2008 Cox et al. 7,420,059 B2 9, 2008 O'Connor et al. (US) 7,482.342 B2 1/2009 D’Orchymont et al. 7,569,571 B2 8/2009 Dong et al. (72) Inventors: Thomas D. Aicher, Ann Arbor, MI (US); 7,696,200 B2 4/2010 Ackermann et al. Peter L. Toogood, Ann Arbor, MI (US); 7,713.996 B2 5/2010 Ackermann et al. Xiao Hu, Northville, MI (US) 7,741,495 B2 6, 2010 Liou et al. 7,799,933 B2 9/2010 Ceccarelli et al. (73) Assignee: Lycera Corporation, Ann Arbor, MI 2006,0004000 A1 1/2006 D'Orchymont et al. 2006/010O230 A1 5, 2006 Bischoff et al. (US) 2007/0010537 A1 1/2007 Hamamura et al. 2007/OO 10670 A1 1/2007 Hirata et al. (*) Notice: Subject to any disclaimer, the term of this 2007/0049556 A1 3/2007 Zhang et al. patent is extended or adjusted under 35 2007/0060567 A1 3/2007 Ackermann et al. -
Studies on the Effects of Paraben Mixtures on MCF-7 Breast Cancer
Studies on the Effects of Paraben Mixtures on MCF-7 Breast Cancer Cells in Culture A thesis submitted in partial fulfilment of the requirements for the Degree of Masters of Science in Biochemistry In the Department of Chemistry At the University of Canterbury New Zealand By Kristie Webber University of Canterbury 2013 Table of Contents Acknowledgements .............................................................................................................................. i Abstract ............................................................................................................................................... ii Abbreviations ..................................................................................................................................... iii List of figures and tables .................................................................................................................... iv 1 Introduction ......................................................................................................................................... 1 1.1 Hormones and the endocrine system ........................................................................................... 2 1.2 Estrogens ....................................................................................................................................... 5 1.2.1 What are estrogens? .............................................................................................................. 5 1.2.2 17β-Estradiol ......................................................................................................................... -
Lambda Cyhalothrin Elicited Dose Response Toxicity On
TOXICOLOGY AND FORENSIC MEDICINE http://dx.doi.org/10.17140/TFMOJ-1-107 Open Journal Research Lambda Cyhalothrin Elicited Dose *Corresponding author Response Toxicity on Haematological, Sujata Maiti Choudhury, PhD Department of Human Physiology with Community Health Hepatic, Gonadal and Lipid Metabolic Vidyasagar University Midnapore, West Bengal, India Biomarkers in Rat and Possible Modulatory Tel. + 9474444646 Fax: + 3222 275 329 Role of Taurine E-mail: [email protected]; [email protected] Rini Ghosh, MSc; Tuhina Das, MSc; Anurag Paramanik, MSc; Sujata Maiti Choudhury, Volume 1 : Issue 2 PhD* Article Ref. #: 1000TFMOJ1107 Department of Human Physiology with Community Health, Vidyasagar University, Midnapore Article History 721102, West Bengal, India Received: September 10th, 2016 Accepted: October 5th, 2016 Published: October 6th, 2016 ABSTRACT Extensive application of pesticides is usually accompanied with serious problems of pollution Citation and health hazards. Lambda-cyhalothrin (LCT), a type II synthetic pyrethroid, is widely used Ghosh R, Das T, Paramanik A, Maiti in agriculture, home pest control and protection of foodstuff. This study designed to evalu- Choudhury S. Lambda cyhalothrin elicited dose response toxicity on hae- ate the dose dependent haematological, hepatic and gonadal toxicity of LCT at different dose matological, hepatic, gonadal and lipid levels in Wistar rat. Investigations were also done to find out the toxic effect of lambda cyha- metabolic biomarkers in rat and possi- lothrin on lipid metabolism in female rat and its amelioration by taurine. Rats were exposed ble modulatory role of taurine. Toxicol to different doses of lambda cyhalothrin over a period of 14 consecutive days. Exposure to Forensic Med Open J. -
Science of the Total Environment 445–446 (2013) 299–305
Science of the Total Environment 445–446 (2013) 299–305 Contents lists available at SciVerse ScienceDirect Science of the Total Environment journal homepage: www.elsevier.com/locate/scitotenv Relationship between urinary triclosan and paraben concentrations and serum thyroid measures in NHANES 2007–2008 Erika S. Koeppe, Kelly K. Ferguson, Justin A. Colacino, John D. Meeker ⁎ Department of Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor, MI, United States HIGHLIGHTS ► Triclosan and parabens are widely used in the US and elsewhere. ► Biomarkers of exposure were examined in relation to serum thyroid hormone levels. ► In adults, we observed inverse associations between parabens and thyroid hormones. ► In adolescents, we observed positive associations between triclosan and total T3. ► Future research is necessary to confirm findings and explore clinical relevance. article info abstract Article history: Triclosan and parabens are broad spectrum antimicrobials used in a range of consumer products. In vitro and Received 28 September 2012 animal studies have suggested the potential for these compounds to disrupt thyroid function, though studies Received in revised form 17 December 2012 in humans have been limited. The objective of the study was to assess the relationship of urinary concentra- Accepted 17 December 2012 tions of triclosan and parabens with serum thyroid measures in a large, representative sample of the US pop- Available online 20 January 2013 ulation. We conducted an exploratory, cross-sectional analysis of data on urinary biomarkers of triclosan and paraben exposure and serum thyroid measures obtained from 1831 subjects (ages≥12 years) as part of the Keywords: – Biomarkers 2007 2008 National Health and Nutrition Examination Survey (NHANES). -
1532 Corticosteroids
1532 Corticosteroids olone; Ultraderm; Malaysia: Synalar†; Mex.: Cortifung-S; Cortilona; Gr.: Lidex; Ital.: Flu-21†; Topsyn; Mex.: Topsyn; Norw.: Metosyn; Pharmacopoeias. In Br. Cremisona; Farmacorti; Flumicin; Fluomex; Fusalar; Lonason; Synalar; Philipp.: Lidemol; Lidex; Singapore: Lidex†; Spain: Klariderm†; Novoter; BP 2008 (Fluocortolone Hexanoate). A white or creamy-white, Norw.: Synalar; NZ: Synalar; Philipp.: Aplosyn; Cynozet; Synalar; Syntop- Switz.: To p s y m ; To p s y m i n ; UK: Metosyn; USA: Lidex; Vanos. ic; Pol.: Flucinar; Port.: Oto-Synalar N; Synalar; Rus.: Flucinar (Флуцинар); odourless or almost odourless, crystalline powder. It exhibits pol- Multi-ingredient: Austria: Topsym polyvalent; Ger.: Jelliproct; Topsym ymorphism. Practically insoluble in water and in ether; very Sinaflan (Синафлан); S.Afr.: Cortoderm; Fluoderm; Synalar; Singapore: polyvalent; Hung.: Vipsogal†; Israel: Comagis; Mex.: Topsyn-Y; Philipp.: Flunolone-V; Spain: Co Fluocin Fuerte; Cortiespec; Fluocid Forte; Fluoder- Lidex NGN; Spain: Novoter Gentamicina; Switz.: Mycolog N; Topsym slightly soluble in alcohol and in methyl alcohol; slightly soluble mo Fuerte; Flusolgen; Gelidina; Intradermo Corticosteroi†; Synalar; Synalar polyvalent; UK: Vipsogal. in acetone and in dioxan; sparingly soluble in chloroform. Pro- Rectal Simple; Swed.: Synalar; Switz.: Synalar; Thai.: Cervicum; Flu- ciderm†; Flunolone-V; Fulone; Supralan; Synalar; UK: Synalar; USA: Capex; tect from light. Derma-Smoothe/FS; DermOtic; Fluonid; Flurosyn†; Retisert; Synalar; Syn- emol; Venez.: Bratofil; Fluquinol Simple†; Neo-Synalar; Neoflu†. Fluocortin Butyl (BAN, USAN, rINNM) ⊗ Fluocortolone Pivalate (BANM, rINNM) ⊗ Multi-ingredient: Arg.: Adop-Tar†; Tri-Luma; Austria: Myco-Synalar; Procto-Synalar; Synalar N; Belg.: Procto-Synalar; Synalar Bi-Otic; Braz.: Butil éster de la fluocortina; Butylis Fluocortinas; Fluocortine Fluocortolone, pivalate de; Fluocortolone Trimethylacetate; Dermobel†; Dermoxin; Elotin; Fluo-Vaso; Neocinolon; Otauril†; Otocort†; Butyle; SH-K-203.